UVC Partners has backed a $13.5m round that came four years after the diagnostic technology spinout of LMU secured a series B featuring UnternehmerTUM.

GNA Biosolutions, a Germany-based molecular diagnostics technology spinout of Ludwig-Maximilans-Universität München, has completed a $13.5m series C round backed by venture capital firm UVC Partners.
UVC Partners, the investment affiliate of Technical University Munich’s tech transfer arm UnternehmerTUM, participated alongside industrial product manufacturer Robert Bosch’s corporate venturing arm, Robert Bosch Venture Capital (RBVC).
The round further included GreyBird Ventures, Occident, Wachstumsfonds Bayern, SHS Gesellschaft für Beteiligungsmanagement, Mey Capital Matrix, KfW and Btov Partners.
GNA provides technology used…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?